and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer.Lakis, Sotirios; Dimoudis, Stefanos; Kotoula, Vassiliki; Alexopoulou, Zoi; Kostopoulos, Ioannis; Koletsa, Triantafyllia;Bobos, Mattheos; Timotheadou, Eleni; Papaspirou, Irene; Efstratiou, Ioannis; Aravantinos, Gerasimos; Karavasilis, Vasilios; Zagouri, Flora; Gogas, Helen; Razis, Evangelia; Pentheroudakis, George; Christodoulou, Christos; Pectasides, Dimitrios; Fountzilas, George.Anticancer Res; 36(5): 2365-78, 2016 May.94.Prognostic significance of Nottingham Prognostic Index in non-metastatic breast cancer.Benderli Cihan, Yasemin; Sarigoz, Talha.J BUON; 21(1): 279, 2016 Jan-Feb.95.Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status.Payandeh, Mehrdad; Shahriari-Ahmadi, Ali; Sadeghi, Masoud; Sadeghi, Edris.Asian Pac J Cancer Prev; 17(3): 1015-8, 2016.96.Ki67 Frequency in Breast Cancers without Axillary Lymph Node Involvement and its Relation with Disease-free Survival.Shandiz, Fatemeh Homaei; Shabahang, Hossein; Afzaljavan, Fahimeh; Sharifi, Nourieh; Tavasoli, Alireza; Afzalaghaee, Monavar; Roshanzamir, Emane; Pasdar, Alireza.Asian Pac J Cancer Prev; 17(3): 1347-50, 2016.97.Highlights of the San Antonio Breast Cancer Symposium 2015: part 1.Benson, John R; Jatoi, Ismail.Future Oncol; 12(7): 893-6, 2016 Apr.98.Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.Benson, John R; Jatoi, Ismail.Future Oncol; 12(7): 897-900, 2016 Apr.99.Locoregional treatment of early breast cancer with isolated tumor cells or micrometastases on sentinel lymph node biopsy.Tallet, Agnes; Lambaudie, Eric; Cohen, Monique; Minsat, Mathieu; Bannier, Marie; Resbeut, Michel; Houvenaeghel, Gilles.World J Clin Oncol; 7(2): 243-52, 2016 Apr 10.100.Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.Tan, Weige; Li, Qian; Chen, Kai; Su, Fengxi; Song, Erwei; Gong, Chang.Oncotarget; 7(9): 10373-85, 2016 Mar 1.101.Validity of immunohistochemistry method in predicting HER-2 gene status and association of clinicopathological variables with it in invasive breast cancer patients.Gheybi, Mohammad Kazzem; Baradaran, Azar; Mohajeri, Mohammad Reza; Ostovar, Afshin; Hajalikhani, Parvaneh;Farrokhi, Shokrollah.APMIS; 124(5): 365-71, 2016 May.102.Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.Laurinavicius, Arvydas; Plancoulaine, Benoit; Rasmusson, Allan; Besusparis, Justinas; Augulis, Renaldas; Meskauskas, Raimundas; Herlin, Paulette; Laurinaviciene, Aida; Abdelhadi Muftah, Abir A; Miligy, Islam; Aleskandarany, Mohammed;Rakha, Emad A; Green, Andrew R; Ellis, Ian O.Virchows Arch; 468(4): 493-502, 2016 Apr.103.Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.Shah, Payal D; Patil, Sujata; Dickler, Maura N; Offit, Kenneth; Hudis, Clifford A; Robson, Mark E.Cancer; 122(8): 1178-84, 2016 Apr 15.104.Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis.Yu, X; Zhang, Z; Wang, Z; Wu, P; Qiu, F; Huang, J.Clin Transl Oncol; 18(5): 497-506, 2016 May.105.Human mammaglobin: A specific marker for breast cancer prognosis.Li, Chuanying; Zhang, Tingguo.J BUON; 21(1): 35-41, 2016 Jan-Feb.106.Intrinsic subtypes and genomic signatures of primary breast cancer and prognosis after systemic relapse.Falato, Claudette; Tobin, Nicholas P; Lorent, Julie; Lindstrom, Linda S; Bergh, Jonas; Foukakis, Theodoros.Mol Oncol; 10(4): 517-25, 2016 Apr.107.The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis.Engels, Charla C; Kiderlen, Mandy; Bastiaannet, Esther; Mooyaart, Antien L; van Vlierberghe, Ronald; Smit, Vincent T H B M; Kuppen, Peter J K; van de Velde, Cornelis J H; Liefers, G J.Mol Oncol; 10(4): 594-600, 2016 Apr.108.The Prognostic Value of Tumor-Infiltrating Lymphocytes in